Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Category Archives: Pivot Pharmaceuticals Inc. PVOTF

MissionIRNewsBreaks – Pivot Pharmaceuticals Inc.’s (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Advanced Technologies Drive Product Development

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) is an emergent biopharmaceutical company engaged in the development and commercialization of pharmaceuticals and nutraceuticals that deliver innovative treatments for unmet healthcare needs. An article discussing the company reads: “The advent … Continue reading

Posted in MissionIRNewsBreaks, Pivot Pharmaceuticals Inc. PVOTF | Leave a comment

MissionIRNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Inks Option Agreement to Acquire Licensing Rights to TriVair™ Drug Delivery System

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) this morning announced that it has signed an option agreement with IP Med Inc. to obtain an exclusive worldwide license for Trivair™ Nasal and Pulmonary Breath-Propelled Drug Delivery Systems™ for the … Continue reading

Posted in MissionIRNewsBreaks, Pivot Pharmaceuticals Inc. PVOTF | Leave a comment

MissionIRNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Inks Manufacturing Agreement with Bio V Pharma Inc.

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) this morning announced that it has signed an exclusive contract manufacturing agreement with Bio V Pharma Inc. (“BioV”). Per the agreement, BioV, a Quebec-based full-service manufacturer of pharmaceutical and nutraceutical products, … Continue reading

Posted in MissionIRNewsBreaks, Pivot Pharmaceuticals Inc. PVOTF | Leave a comment

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Targeting Growing CBD Pet Market with New Product Line

Company’s new products are designed to address issues such as inflammation, joint pain, post-surgery pain and skin disorders in pets CBD pet market is heating up, with a growing number of cannabis companies already manufacturing products for this niche Pet … Continue reading

Posted in Pivot Pharmaceuticals Inc. PVOTF | Leave a comment

MissionIRNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Subsidiary Secures Manufacturing Facility in California

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) this morning announced that its wholly-owned U.S. subsidiary, Pivot Naturals LLC, (“PNL”), has entered a lease agreement for a manufacturing facility in Costa Mesa, California’s Measure “X” Zone. PNL will immediately … Continue reading

Posted in MissionIRNewsBreaks, Pivot Pharmaceuticals Inc. PVOTF | Leave a comment

MissionIRNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) to Develop Additives and Formulations for Cannabis Beverage Market

Vancouver-based biopharmaceutical company Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) this morning announced that it has initiated development of CBD and THC additives and formulations for the multi-billion dollar beverage industry using its patented Ready-To-Infuse-Cannabis (“RTIC”) Powder and … Continue reading

Posted in MissionIRNewsBreaks, Pivot Pharmaceuticals Inc. PVOTF | Leave a comment

MissionIRNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Fast-tracks Development for CBD Pet Product Line

Vancouver-based biopharmaceutical company Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) this morning announced that it has accelerated development of several cannabidiol (“CBD”) products for the domestic pet food market. Pivot’s pet product line will be marketed under the … Continue reading

Posted in MissionIRNewsBreaks, Pivot Pharmaceuticals Inc. PVOTF | Leave a comment

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Cements Its Position in the Expanding Cannabis Industry

Global patents for innovative formulations and drug delivery platforms Strong development pipeline for cannabinoid-based pharmaceutical and nutraceutical products Capabilities to manufacture products of a quality unmatched by other industry players Canadian biopharmaceutical company Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) … Continue reading

Posted in Pivot Pharmaceuticals Inc. PVOTF | Leave a comment

MissionIRNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Subsidiary Enters Manufacturing and Supply Agreement in California

Vancouver-based biopharmaceutical company Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) this morning announced that its wholly-owned California subsidiary, Pivot Naturals, LLC, has signed a definitive manufacturing and supply agreement with Stoney LLC, a leading brand of cannabis products … Continue reading

Posted in MissionIRNewsBreaks, Pivot Pharmaceuticals Inc. PVOTF | Leave a comment

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) Aims for Rapid Delivery of Cancer, Skin, Female Sexual Dysfunction Therapies

Pivot developing nutraceutical and pharmaceutical therapies based on cannabis derivatives Female sexual dysfunction market expected to exceed booming male products market Skin and oral delivery of Pivot products driven by innovative technologies The advent of modern licensing controls for over-the-counter … Continue reading

Posted in Pivot Pharmaceuticals Inc. PVOTF | Leave a comment